Oral GLP-1 drugs may quiet the brain’s food craving circuit

Newer oral drugs related to semaglutide medications such as Ozempic reduced pleasure-driven eating in mice by quieting a deep brain reward circuit. The finding could open new avenues for understanding food cravings and potentially treating substance use disorder.

Source: ScienceDaily

Leave a Reply

Your email address will not be published. Required fields are marked *